Head of the Sanskrit Department and Dean Dr. CN Vijayakumari has filed a complaint with the Vice Chancellor against awarding ...
A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback